在患有由肺炎引起的塑性支气管炎的儿童中,多发性溢血的危险因素
Xiaoliang Lin1,2, Enhui Xu1, Tan Zhang1
1Department of Respiratory Medicine, Xiamen Children's Hospital (Children's Hospital of Fudan University at Xiamen), Xiamen, China.
这项研究确定了儿科塑性支气管炎的临床特征和多发性溢液 (PE) 的危险因素. 升高的C-反应蛋白 (CRP) 和乳酸脱酶 (LDH) 预测了患有肺炎相关的塑性支气管炎的儿童的PE风险.
科学领域:
- 儿科肺病学 儿科肺病学
- 临床医学 临床医学
- 呼吸道疾病 呼吸道疾病
背景情况:
- 塑性支气管炎是儿童罕见但严重的疾病,通常与肺炎有关.
- 胸腔溢液 (PE) 是一种严重的并发症,需要仔细监测和风险评估.
- 了解PE的临床特征和风险因素对于及时干预至关重要.
研究的目的:
- 为了研究诊断为肺炎的二次性塑性支气管炎的儿童的临床特征.
- 在这个儿科群体中识别和评估与肺溢液 (PE) 发展相关的风险因素.
主要方法:
- 一项回顾性研究分析了2017年1月至2023年4月期间住院的69名患有塑性支气管炎的儿童.
- 参与者根据PE的存在或不存在进行分组,并分析临床表现和实验室发现.
- 使用接收器操作特征 (ROC) 曲线和多变量逻辑回归来确定PE风险因素.
主要成果:
- 在PE和没有PE的组之间没有观察到性别,年龄或病因方面的显著差异.
- 在发烧持续时间,C-反应蛋白 (CRP),专蛋白和乳酸脱酶 (LDH) 中发现了显著的差异.
- 增加的CRP (OR 8.358) 和LDH (OR 5.851) 被确定为PE的显著预测因子,组合模型的AUC为0.797.
结论:
- 结合检测CRP和LDH有效预测肺炎诱导的塑性支气管炎的儿童的肺部溢液的风险.
- 这些生物标志物可以帮助早期风险分层和儿童塑性支气管炎的管理.
- 进一步的研究可能会完善这种情况下对PE的预测模型.
更多相关视频
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
05:50International Expert Consensus and Recommendations for Neonatal Pneumothorax Ultrasound Diagnosis and Ultrasound-guided Thoracentesis Procedure
Published on: March 12, 2020
相关概念视频
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pulmonary Cycle: Exhalation
Pneumonia II: Pathophysiology
